Mark Mcdade Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Mark Mcdade is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 518 shares of TALS, which is worth approximately $1,408. The most recent transaction as insider was on Oct 19, 2023, when has been sold 518 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 518
0% 3M change
n/a 12M change
Total Value Held $1,408

MARK MCDADE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2023
BUY
Grant, award, or other acquisition
-
518 Added 50.0%
518 Common Stock

Also insider at

ICVX
Icosavax, Inc. Healthcare
MM

Mark Mcdade

Director
Bellevue, WA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS